Gastroesophageal reflux disease

Journal of Gastroenterology

Volumn 45, Issue 8, 2010, Pages 808-815

  Fock, Kwong Ming ^a   Poh, Choo Hean ^a  

^a CHANGI GENERAL HOSPITAL   (Singapore)

Author keywords

Baclofen; Gastroesophageal reflux disease; GERD; NERD

Indexed keywords

PROTON PUMP INHIBITOR;

AGE; AGED; ASIA; ESOPHAGEAL PH MONITORING; GASTROESOPHAGEAL REFLUX; HEARTBURN; HOSPITALIZATION; HUMAN; PATHOPHYSIOLOGY; PH; PREVALENCE; REVIEW;

AGE FACTORS; AGED; ASIA; ESOPHAGEAL PH MONITORING; GASTROESOPHAGEAL REFLUX; HEARTBURN; HUMANS; HYDROGEN-ION CONCENTRATION; PREVALENCE; PROTON PUMP INHIBITORS; SEVERITY OF ILLNESS INDEX;

EID: 79952025704     PISSN: 09441174     EISSN: 14355922     Source Type: Journal    
DOI: 10.1007/s00535-010-0274-9     Document Type: Review

References (65)

1. Dent J, El Serag H, Wallender M, Johansson S. Epidemiology of gastroesophageal reflux disease: a systematic review. Gut. 2005;54:710-7. (Pubitemid 40559260)
2. Camilleri M, Dubois D, Coulie B, Jones M, Kahrilas PJ, Rentz AM, et al. Prevalence and socioeconomic impact of upper gastrointestinal disorders in the United States: results of the US Upper Gastrointestinal Study. Clin Gastroenterol Hepatol. 2005;3:543-52. (Pubitemid 40824747)
3. Fock KM, Talley NJ, Hunt R, Fass R, Nandurkar S, Lam SK, et al. Report of the Asia-Pacific consensus on the management of gastroesophageal reflux disease. J Gastroenterol Hepatol. 2004;19:357-67. (Pubitemid 38570184)
4. Fock KM, Talley NJ, Fass R, Goh KL, Katelaris P, Hung R, et al. Asia-Pacific consensus on the management of gastroesophageal reflux disease: update. J Gastroenterol Hepatol. 2008;23:8-22. (Pubitemid 350265214)
5. Nimish V, Sander V, Kahrilas P, Dent J, Jones R, Global Consensus Group. The montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol. 2006;101:1900-20.
6. Tack J, Fass R. Review article: approaches to endoscopic-negative reflux disease: part of the GERD spectrum or a unique acid-related disorder? Aliment Pharmacol Ther. 2004;19(Suppl 1):28-34. (Pubitemid 38253489)
7. Klauser AG, Schindlbeck NE, Muller-Lissner SA. Symptoms in gastroesophageal reflux disease. Lancet. 1990;335:205-8.
8. Carlsson R, Dent J, Bolling-Sternevald E, Johnsson F, Junghard O, Lauritsen K, et al. The usefulness of a structured questionnaire in the assessment of symptomatic gastroesophageal reflux disease. Scand J Gastroenterol. 1998;33:1023-9. (Pubitemid 28505643)
9. Ho KY, Gwee KA, Khor JL, Selamat DS, Yeoh KG. Validation of a graded response questionnaire for the diagnosis of gastroesophageal reflux disease in an Asian primary care population. J Clin Gastroenterol. 2008;42:680-6.
10. Wu W. Ancillary tests in the diagnosis of gastroesophageal reflux disease. Gastroenterol Clin North Am. 1990;19:671-82. (Pubitemid 20337448)
11. Dent J, Brun J, Fendrick AM, Fennerty MB, Janssens J, Kahrilas PJ, et al. An evidence-based appraisal of reflux disease management - the Geneval Workshop Report. Gut. 1999;44:S1-16.
12. Yoshikawa I, Yamasaki M, Yamasaki T, Kume K, Otsuki M. Lugol chromoendoscopy as a diagnostic tool in so called endoscopy negative GERD. Gastrointest Endosc. 2005;62:698-703. (see also pp 752, 754).
13. Sharma P, Wani S, Bansal A, Hall S, Puli S, Mathur S, Rastogi A. A feasibility trial of narrow band imaging endoscopy in patients with gastroesophageal reflux disease. Gastroenterology. 2007;133:454-64. (Pubitemid 47187359)
14. Fock KM, Teo EK, Ang TL, Tan JY, Law NM. The utility of narrow band imaging in improving the endoscopic diagnosis of gastroesophageal reflux disease. Clin Gastroenterol Hepatol. 2009;7:54-9.
15. Dent J. Microscopic esophageal mucosal injury in nonerosive reflux disease. Clin Gastroenterol Hepatol. 2007;5:4-16.
16. Tobey NA, Hosseini SS, Argote CM, Dobrucali AM, Awayda MS, Orlando RC. Dilated Intercellular spaces and shunt permeability in nonerosive acid-damaged esophageal epithelium. Am J Gastroenterol. 2004;99:13-22. (Pubitemid 38679095)
17. Armstrong D, Vieth M, Fiocca R, Deprez P, Kuipers E, Holmqinst L, et al. Are endoscopy negative GERD and reflux esophagitis different disease? Baseline histology in GERD patients off-therapy - the CHEER Study. Gastroenterology. 2003;124:A-416.
18. Vakil N. Review article: how valuable are proton-pump inhibitors in establishing a diagnosis of gastroesophageal reflux disease? Aliment Pharmacol Ther. 2005;22(Suppl 1):64-9. (Pubitemid 41153081)
19. Gasiorowska A, Fass R. The proton pump inhibitor (PPI) test in GERD. Does it still have a role? J Clin Gastroenterol. 2008;42:867-74.
20. Fass R, Ofman J, Sampliner R, Camargo L, Wendel C, Fennerty MB. The omeprazole test is as sensitive as 24 hour esophageal pH monitoring in diagnosing gastroesophageal reflux disease in symptomatic patients with erosive esophagitis. Aliment Pharmacol Ther. 2000;14:389-96. (Pubitemid 30199214)
21. Euler A, Byrne W. Twenty-four hour esophageal intraluminal pH probe testing: a comparative analysis. Gastroenterology. 1981;80:957-61. (Pubitemid 11113036)
22. Fass R, Fennerty M, Ofman JJ, Gralnek IM, Johnson C, Camargo E, et al. The clinical and economic value of a short course of omeprazole in patients with non-cardiac chest pain. Gastroenterology. 1998;115:42-9. (Pubitemid 28307286)
23. Martinez S, Malagon IB, Garewal HS, Cui H, Fass R. Non-erosive reflux disease (NERD)-acid reflux and symptom pattern. Aliment Pharmacol Ther. 2003;17:537-45. (Pubitemid 36384812)
24. Des Varannes SB, Mion F, Ducrotte P, Zerbib F, Denis P, Ponchon T, et al. Simultaneous recording of esophageal acid exposure with conventional pH monitoring and a wireless system (Bravo). Gut. 2005;54:1682-6.
25. Sifrim D, Castell D, Dent J, Kahrilas PJ. Gastroesophageal reflux monitoring: review and consensus report on detection and definitions of acid, non acid and gas reflux. Gut. 2004;53:1024-31. (Pubitemid 38824163)
26. Bredenoord AJ, Weusten BLAM, Timmer R, Conchillo JM, Smout AJPM. Addition of esophageal impedance monitoring to pH monitoring increases the yield of symptom association analysis in patients off PPI therapy. Am J Gastroenterol. 2006;101:453-9. (Pubitemid 43340918)
27. Lichtenstein DR, Cash BD, Davila R, Baron TH, Adler DG, Anderson MA, et al. Standards of Practice Committee. Role of endoscopy in the management of GERD. Gastrointest Endosc. 2007;66:219-24. (Pubitemid 47069308)
28. Poh CH, Gasiorowska A, Navarro-Rodriguez T, Willis MR, Hargadon D, Noelck N, et al. Upper GI tract findings in patients with heartburn in whom proton pump inhibitor treatment failed versus those not receiving antireflux treatment. Gastrointest Endosc. 2010;71:28-34.
29. Kaltenbach T, Crockett S, Gerson LB. Are lifestyle measures effective in patients with gastroesophageal reflux disease? An evidence-based approach. Arch Intern Med. 2006;166:965-71.
30. Weberg R, Berstad A. Symptomatic effect of a low-dose antacid regimen in reflux esophagitis. Scand J Gastroenterol. 1989;24:401-6. (Pubitemid 19141424)
31. Carling L, Cronstedt J, Engqvist A, Kagevi I, Nyström B, Svedberg LE, et al. Sucralfate versus placebo in reflux esophagitis. A double-blind multicenter study. Scand J Gastroenterol. 1988;23:1117-24.
32. Tytgat GNJ. Review article: treatment of mild and severe cases of GERD. Aliment Pharmacol Ther. 2002;16(Suppl 4):73-8. (Pubitemid 34595622)
33. Colin-Jones DG. The role and limitations of H2-receptor antagonists in the treatment of gastroesophageal reflux disease. Aliment Pharmacol Ther. 1995;9(Suppl 1):9-14.
34. Chiba N, De Gara CJ, Wilkinson JM, Hunt R. Speed of healing and symptom relief in grade II to IV gastroesophageal reflux disease: a meta-analysis. Gastroenterology. 1997;112:1798-810. (Pubitemid 27240763)
35. DeVault KR, Castell DO. The Practice Parameters Committee of the American College of Gastroenterology. Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease. Am J Gastroenterol. 1999;94:1434-42. (Pubitemid 29260426)
36. Carlsson R, Dent J, Watts R, Riley S, Sheikh R, Hatlebakk J, et al. Gastroesophageal reflux disease in primary care: an international study of different treatment strategies with omeprazole. Eur J Gastroenterol Hepatol. 1998;10:119-24. (Pubitemid 28101879)
37. Hallerback B, Unge P, Carling L, et al. Omeprazole or ranitidine in long term treatment of reflux esophagitis. Gastroenterology. 1994;107:1305-11. (Pubitemid 24328266)
38. Wilde MI, McTavish D. Omeprazole. An update of its pharmacology and therapeutic use in acid-related disorders. Drugs. 1994;48:91-132. (Pubitemid 24223942)
39. Koury SI, Stone CK, La Charite DD. Omeprazole and the development of acute hepatitis. Eur J Emerg Med. 1998;5:467-9.
40. Yip D, Kovac S, Jardine M, Horvath J, Findlay M. Omeprazole induced interstitial nephritis. J Clin Gastroenterol. 1997;25:450-2.
41. Singh P, Indaram A, Greenberg R, Visvalingam V, Bank S. Long term omeprazole therapy for reflux esophagitis: follow up in serum gastrin levels, EC cell hyperplasia and neoplasia. World J Gastroenterol. 2000;6:789-92. (Pubitemid 32015791)
42. Juurlink DN, Gomes T, Ko DT, Szmitko PE, Austin PC, Tu JV, et al. A population-based study of the drug interaction between proton pump inhibitors and clopidrogrel. CMAJ. 2009;180:713-8.
43. Futagami S, Iwakiri K, Shindo T, Kawagoe T, Horie A, Shimpuku M, et al. The prokinetic effect of mosapride citrate combined with omeprazole therapy improves clinical symptoms and gastric emptying in PPI-resistant NERD patients with delayed gastric emptying. J Gastroenterol. 2010;45:413-21.
44. Kim YS, Kim TH, Choi CS, Shon YW, Kim SW, Seo GS, et al. Effect of itopride, a new prokinetic, in patients with mild GERD: a pilot study. World J Gastroenterol. 2005;11(27):4210-4. (Pubitemid 41086873)
45. Dodds WJ, Dent J, Hogan WJ, Helm JF, Hauser R, Patel GK, et al. Mechanisms of gastroesophageal reflux in patients with reflux esophagitis. N Engl J Med. 1982;307:1547-52. (Pubitemid 13245429)
46. Vela MF, Tutuian R, Katz PO, Castell DO. Baclofen decreases acid and non-acid post prandial gastroesophageal reflux measured by combined multichannel intraluminal impedance and pH. Aliment Pharmacol Ther. 2003;17:243-51. (Pubitemid 36174255)
47. Lundell L, Miettinen P, Myrvold HE, Pedersen SA, Thor K, Lamm M, et al. Long term management of gastroesophageal reflux disease with omeprazole or open antireflux surgery: results of a prospective, randomized clinical trial. Eur J Gastroenterol Hepatol. 2000;12:879-87. (Pubitemid 30663900)
48. Lafullarde T, Watson D, Jamieson G, Meyers JC, Game PA, Devitt PG. Laparoscopic Nissen fundoplication. Arch Surg. 2001;136:180-4.
49. Spechler S. Comparison of medical and surgical therapy for complicated gastroesophageal reflux disease in veterans. N Engl J Med. 1992;326:786-92.
50. Lundell L, Attwood S, Fiocca R, Galmiche JP, Hatlebakk J, Lind T, et al. Comparison laparoscopic antireflux surgery with esomeprazole in the management of patients with chronic gastroesophageal reflux disease: a 3-year interim analysis of the LOTUS trial. Gut. 2008;57:1207-13.
51. Kozarek R, Low D, Raltz S. Complications associated with laparoscopic anti-reflux surgery: one multispecialty clinic's experience. Gastrointest Endosc. 1997;46:527-31. (Pubitemid 28018548)
52. Galmiche J, Zerbib F. Laparoscopic fundoplication is the treatment of choice for gastroesophageal reflux disease. Gut. 2002;51:472-4.
53. Lundell L, Miettinen P, Myrvold HE, Hatlebakk JG, Wallin L, Malm A, et al. Seven-year follow-up of randomized clinical trial comparing proton pump inhibition with surgical therapy for reflux esophagitis. Br J Surg. 2007;94:198-203. (Pubitemid 46340400)
54. Soot S, Eshraghi N, Farahmand M, Sheppard BC, Deveney CW. Transition from open to laparoscopic fundoplication: the learning curve. Arch Surg. 1999;134:278-81.
55. DeMeester TR, Johnson LF, Joseph GJ, Toscano MS, Hall AW, Skinner DB. Patterns of gastroesophageal reflux in health and disease. Ann Surg. 1976;184:459-70.
56. Poh CH, Allen L, Gasiorowska A, Navarro-Rodriguez T, Quan SF, Malagon I, et al. Conscious awakening are commonly associated with acid-reflux events in patients with gastroesophageal reflux disease. Clin Gastroenterol Hepatol. 2010 (in press).
57. Smith PM, Kerr GD, Cockel R, Ross BA, Bate CM, Brown P, et al. A comparison of omeprazole and ranitidine in the prevention of reoccurrence of benign esophageal stricture. Restore Investigator Group. Gastroenterology. 1994;107:1312-8. (Pubitemid 24328267)
58. Raiha IJ, Imprivaara O, Seppala M, Sourander LB. Prevalence and characteristics of symptomatic gastroesophageal reflux disease in the elderly. J Am Geriatr Soc. 1992;40:1209-11.
59. Zhu H, Pace F, Sangaletti O, Bianchi PG. Features of symptomatic gastroesophageal reflux in elderly patients. Scand J Gastroenterol. 1993;28:235-8. (Pubitemid 23080681)
60. Plant RL. Anatomy and physiology of swallowing in adults and geriatrics. Otolaryngol Clin North Am. 1998;31:447-88.
61. Raiha I, Hietanen E, Sourander L. Symptoms of gastro-esophageal reflux disease in elderly people. Age Ageing. 1991;20:365-70.
62. Mold JW, Reed LE, Davis AB, Allen ML, Decktor DL, Robinson M. Prevalence for gastroesophageal reflux in elderly patients in a primary care setting. Am J Gastroenterol. 1991;86:965-70.
63. O'Connell MB, Madden DM, Murray AM, Heaney RP, Kerzner LJ. Effects of proton pump inhibitors on calcium carbonate absorption in women: a randomized crossover trial. Am J Med. 2005;118:778-81. (Pubitemid 40897665)
64. Yang YX, Lewis JD, Epstein S, Epstein S, Metz DC. Long-term proton pump inhibitor therapy and risk of hip fracture. JAMA. 2006;296:2947-53. (Pubitemid 46021498)
65. Laheij RJF, Stukenboom MCJM, Hassing RJ, Dieleman J, Stricker BHC, Jansen JBMJ. Risk of community-acquired pneumonia and use of gastric acid suppressive drugs. JAMA. 2004;292:1955-60. (Pubitemid 39411203)